Orbis Holdings’s Celgene Corp CELG Stock Holding History

Orbis Holdings’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$112M	Buy	936,381 +433,809	+86%	+$50.2M	0.88%	30
2015 Q3	$54.4M	Sell	502,572 -31,172	-6%	-$3.87M	0.46%	43
2015 Q2	$61.8M	Sell	533,744 -390,104	-42%	-$44.6M	0.47%	43
2015 Q1	$107M	Sell	923,848 -733,879	-44%	-$87.7M	0.85%	34
2014 Q4	$185M	Sell	1,657,727 -1,175,202	-41%	-$124M	1.41%	25
2014 Q3	$269M	Buy	2,832,929 +897,072	+46%	+$81M	2.13%	16
2014 Q2	$166M	Buy	+1,935,857	New	+$147M	1.37%	25

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Orbis Holdings's CELG Position: Q4 2015 in Review

Orbis Holdings increased its Celgene Corp (CELG) stake by 86% in Q4 2015, buying an estimated $50.2M and bringing the position to 936,381 shares worth $112M. The position accounts for 0.88% of the portfolio, ranked #30.

Orbis Holdings first reported a position in CELG in Q2 2014 and has held it in 7 quarters since. The position peaked at $269M in Q3 2014. 1,247 funds tracked by Wall St. Rank hold CELG as of Q4 2015.

Orbis Holdings held 936,381 shares of Celgene Corp worth $112M as of Q4 2015.
Orbis Holdings bought 433,809 Celgene Corp shares in Q4 2015, an estimated $50.2M.
Celgene Corp made up 0.88% of Orbis Holdings's portfolio in Q4 2015, its #30 holding.
Orbis Holdings first reported a position in Celgene Corp in Q2 2014 and has held it in 7 quarters since.
Orbis Holdings's Celgene Corp position peaked at $269M in Q3 2014.
1,247 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2015.

Based on Orbis Holdings's 13F filing for Q4 2015, filed 16 Feb 2016.